Last updated: 2026-09-05 04:33:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
West Pharmaceutical Services, Inc. (WST) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NYSE. The stock is currently priced at $339.93, with a market capitalization of $24.11B and a P/E ratio of 42.70. Over the past 52 weeks, its price has ranged from $223.83 to $386.00. This page covers its latest market performance, valuation, price trends and company information.
$24.11B | |
$340.99 | |
$475.35 | |
$9.29 | |
$342.73 | |
267.83K | |
-- | |
42.70 | |
$386.00 | |
$223.83 | |
0.24% | |
-- |
West Pharmaceutical Services, Inc. (WST) last closed at $342.73 as of 2026-09-04 23:54:00, unchanged from the previous close of $342.73.
During the latest regular trading session, WST traded between $9.29 and $475.35, with a volume of 267.83K shares. The closing price was near the upper end and near the upper end of its 52-week range.
Over the past seven days, West Pharmaceutical Services, Inc. (WST) moved from $336.25 to $339.93, representing a gain of 1.09% ($3.68).
The stock traded between $337.39 and $342.91 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 412.99 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 71.6%
WST is currently trading at $339.93, placing it 71.6% of the way from its 52-week low of $223.83 to its 52-week high of $386.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 10800 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of West Pharmaceutical Services, Inc. (WST) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.